Models incorporating physical, laboratory and gut metabolite markers can be used to predict severe hepatic steatosis in MAFLD patients

Models incorporating physical, laboratory and gut metabolite markers can be used to predict severe hepatic steatosis in MAFLD patients

Abstract Metabolic‐associated fatty liver disease (MAFLD) induced‐severe hepatic steatosis poses significant health risks. Early prediction of this condition is crucial for prompt intervention. Short‐chain fatty acids (SCFAs) and tryptophan are gut metabolites correlated with MAFLD pathogenesis in t...

Full description

Saved in:
Bibliographic Details
Main Authors: Yi‐Hsuan Lin, Ching‐Hsiang Wang, Yen‐Hsun Huang, Hsiao‐Chin Shen, Wei‐Kai Wu, Hsiao‐Yun Yeh, Chia‐Chang Huang, Chien‐Wei Su, Ying‐Ying Yang, Ming‐Shiang Wu, Han‐Chieh Lin, Ming‐Chih Hou
Format: Article
Language:English
Published: Wiley 2024-12-01
Series:Kaohsiung Journal of Medical Sciences
Subjects:
fatty liver
metabolic‐associated fatty liver disease
short‐chain fatty acids
tryptophan
Online Access:https://doi.org/10.1002/kjm2.12904
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/kjm2.12904

Similar Items